Adalvo Ltd. Pharmadox Healthcare Ltd.

Poland

All drugs from this manufacturer

  • BANAVIN

    The medicine is used in adults for the treatment of major depressive episodes. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, feelings of worthlessness, or loss of interest.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 5 mg

    ATC: N06AX26

  • It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, tension, sleep disturbances, loss of appetite, difficulty concentrating, or loss of interest.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 10 mg

    ATC: N06AX26

  • The medicine is used in adults for the treatment of major depressive episodes. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, or loss of interest in favorite activities.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 15 mg

    ATC: N06AX26

  • The medicine is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, tension, sleep disturbances, loss of appetite, difficulty concentrating, or loss of interest.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 20 mg

    ATC: N06AX26

  • It is used in adults to relieve symptoms of an overactive bladder, such as a sudden urge to urinate, the need to use the toilet more frequently, and loss of bladder control.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    mirabegron 50 mg

    ATC: G04BD12

  • The medicine is used in adults to treat symptoms of an overactive bladder, such as a sudden urge to urinate, frequent urination, and loss of bladder control. In children and adolescents (from 3 to 18 years old), it is used to treat neurogenic detrusor overactivity to increase bladder capacity and limit urinary leakage.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    mirabegron 50 mg

    ATC: G04BD12

  • It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, anxiety, sleep problems, loss of appetite, difficulty concentrating, or loss of interest.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 5 mg

    ATC: N06AX26

  • It is used in the treatment of major depressive episodes in adults. It helps alleviate symptoms such as sadness, anxiety, sleep problems, loss of appetite, difficulty concentrating, or loss of interest.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 10 mg

    ATC: N06AX26

  • The medicine is used to treat major depressive episodes in adults. It helps to alleviate symptoms such as sadness, internal tension, anxiety, sleep disturbances, decreased appetite, difficulty concentrating, feelings of worthlessness, or loss of interest in favorite activities.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 15 mg

    ATC: N06AX26

  • It is used in the treatment of major depressive episodes in adults. It helps to alleviate symptoms such as sadness, internal tension, sleep disturbances, decreased appetite, difficulty concentrating, or loss of interest in favorite activities.

    Dosage form: tablets, film-coated

    Active substance Dosage
    vortioxetine 20 mg

    ATC: N06AX26

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 25 mg

    ATC: L04AX04

  • The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 2.5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 7.5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 20 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 25 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 2.5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 2.5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • The medicine is intended for adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 7.5 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 20 mg

    ATC: L04AX04

  • The medicine is used in adult patients for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and follicular lymphoma (FL).

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 25 mg

    ATC: L04AX04

  • This medicine is used in adults to treat symptoms of an overactive bladder, such as a sudden urge to urinate, the need to urinate more frequently, and loss of bladder control.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    mirabegron 50 mg

    ATC: G04BD12